202 related articles for article (PubMed ID: 25577957)
21. Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1.
Liu J; Choy KW; Chan LW; Leung TY; Tam PO; Chiang SW; Lam DS; Pang CP; Lai TY
Clin Exp Ophthalmol; 2010 Jan; 38(1):37-42. PubMed ID: 20447099
[TBL] [Abstract][Full Text] [Related]
22. Genetic analysis and prenatal diagnosis of 20 Chinese families with oculocutaneous albinism.
Xu C; Xiang Y; Li H; Xu Y; Mao Y; Zhou L; Xu X; Tang S
J Clin Lab Anal; 2021 Feb; 35(2):e23647. PubMed ID: 33124154
[TBL] [Abstract][Full Text] [Related]
23. Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the
Monfermé S; Lasseaux E; Duncombe-Poulet C; Hamel C; Defoort-Dhellemmes S; Drumare I; Zanlonghi X; Dollfus H; Perdomo Y; Bonneau D; Korobelnik JF; Plaisant C; Michaud V; Pennamen P; Rooryck-Thambo C; Morice-Picard F; Paya C; Arveiler B
Br J Ophthalmol; 2019 Sep; 103(9):1239-1247. PubMed ID: 30472657
[TBL] [Abstract][Full Text] [Related]
24. Rapid genetic analysis of oculocutaneous albinism (OCA1) using denaturing high performance liquid chromatography (DHPLC) system.
Lin SY; Chien SC; Su YN; Lee CN; Chen CP
Prenat Diagn; 2006 May; 26(5):466-70. PubMed ID: 16570240
[TBL] [Abstract][Full Text] [Related]
25. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene.
Sengupta M; Mondal M; Jaiswal P; Sinha S; Chaki M; Samanta S; Ray K
Br J Dermatol; 2010 Sep; 163(3):487-94. PubMed ID: 20426782
[TBL] [Abstract][Full Text] [Related]
27. TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestations.
Chen C; Li J; Wang B; Wang Y; Yu X
Exp Eye Res; 2024 Feb; 239():109761. PubMed ID: 38145795
[TBL] [Abstract][Full Text] [Related]
28. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism.
Wei A; Wang Y; Long Y; Wang Y; Guo X; Zhou Z; Zhu W; Liu J; Bian X; Lian S; Li W
J Invest Dermatol; 2010 Mar; 130(3):716-24. PubMed ID: 19865097
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
31. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
[TBL] [Abstract][Full Text] [Related]
32. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
[TBL] [Abstract][Full Text] [Related]
33. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
[TBL] [Abstract][Full Text] [Related]
34. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
35. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan.
Tsai CH; Tsai FJ; Wu JY; Lin SP; Chang JG; Yang CF; Lee CC
Hum Mutat; 1999 Dec; 14(6):542. PubMed ID: 10571953
[TBL] [Abstract][Full Text] [Related]
36. Functional validation of the albinism-associated tyrosinase T373K SNP by CRISPR/Cas9-mediated homology-directed repair (HDR) in rabbits.
Song Y; Zhang Y; Chen M; Deng J; Sui T; Lai L; Li Z
EBioMedicine; 2018 Oct; 36():517-525. PubMed ID: 30274819
[TBL] [Abstract][Full Text] [Related]
37. Mapping the TYR gene reveals novel and previously reported variants in Eastern Indian patients highlighting preponderance of the same changes in multiple unrelated ethnicities.
Ganguly K; Dutta T; Saha A; Sarkar D; Sil A; Ray K; Sengupta M
Ann Hum Genet; 2020 May; 84(3):303-312. PubMed ID: 32115698
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
Hutton SM; Spritz RA
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):868-72. PubMed ID: 18326704
[TBL] [Abstract][Full Text] [Related]
39. Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.
Xu B; Chen X; Li H
Altern Ther Health Med; 2023 Oct; 29(7):278-283. PubMed ID: 37471664
[TBL] [Abstract][Full Text] [Related]
40. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
Preising MN; Forster H; Gonser M; Lorenz B
Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
